McKesson selected by VA as prime pharmaceutical provider
McKesson has been selected by the Department of Veterans Affairs, which runs the nation’s largest integrated healthcare system, to continue as the prime pharmaceutical supplier for the agency.
Under the new agreement, which takes effect in Aug. 2020, McKesson will supply all of the VA's medical centers and outpatient clinics, as well as the VA's consolidated mail outpatient pharmacies. The initial two-year contract includes options for up to three, two-year extensions.
“McKesson has had the privilege of supporting the VA as their prime pharmaceutical supplier since 2004,” said McKesson’s CEO Brian Tyler, “We are honored to once again be selected for the important responsibility of serving those who serve us and providing quality care for our veterans.”
As part of the contract award, McKesson will continue to supply pharmaceuticals to more than 750 locations, including more than 270 medical centers, as well as the VA's seven consolidated mail outpatient pharmacies.
McKesson is the largest non-defense vendor serving the U.S. Department of Veterans Affairs, Department of Defense, and other government branches.